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Interventions provide unique opportunities to learn about the natural history of infectious 
diseases, and one such intervention is the global rollout of pneumococcal conjugate vaccine. 
This is a vast experiment in natural selection, during which specific capsular types contained 
in 10–13-valent vaccines are increasingly being prevented from circulating in the human 
population. These types were chosen on the basis of their prevalence among invasive 
pneumococcal disease isolates, so by definition they represent a selection of the dominant 
invasive pneumococcal serotypes. The remaining ≥80 serotypes are then increasingly free to 
compete in an environment without their most invasive competitors. We can measure the 
invasive potential of these “replacement” strains most simply by comparing their prevalence 
in collections of carriage strains versus invasive strains. This allows the development of an 
invasiveness index [1–6], which has until now been based entirely on capsular types.
Thus, serotypes 1, 5, and 7F, which are rarely detected among carriage isolates and almost 
exclusively found in collections of invasive disease isolates, have the highest invasive 
potential, which is simply a ratio of their occurrence in collections of invasive versus 
carriage strains. A caveat of this approach is that these studies on carriage have used culture 
only, so as molecular or immunologic methods are developed to identify low density 
carriage, these invasive indices may change.
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There are some further caveats to these comparisons, such as taking the invasive strains and 
carriage strains from the same population in time and place, and these fundamentals are met 
in the article by Browall et al [7], from the Karolinska Institute in Sweden. They examined a 
collection of 550 carriage strains and 165 invasive strains, all recovered from children <18 
years of age in the Stockholm area between 1997 and 2004, presumably before the 
introduction conjugate vaccine in much of that population. The mean age of 2.5 years among 
subjects with invasive pneumococci and 3.3 years among those carrying pneumococci means 
that only a fraction of the subjects in each group were <1 year old, the age when most 
mortality due to pneumococcal infection occurs in children in developing countries. 
Nonetheless, these data offer a useful comparison between invasive and carriage strains in 
the same community in a developed country.
The most important new contribution of the study is that invasiveness was not only an 
attribute of serotype, although Browall et al detected typically high odds ratios (ORs) of the 
invasive potential of serotypes 1, 7F, 14, 18C, and 19A. Intriguingly, among 107 isolates, all 
of sero-type 6B and clonal complex 138, the authors found 3 different pulsed-field gel 
electrophoresis (PFGE) types with differing levels of invasiveness. One PFGE sub-type, 
comprising 7 strains, was significantly associated with invasiveness (OR, 20.6; 95% 
confidence interval [CI], 2.5–949.7), whereas no such association existed for the other two. 
Similar observations were made for a specific PFGE type within clonal complex 113, a 
complex predominantly of serotype 18C, which conferred an invasive potential OR of 17.1 
(95% CI, 1.9– 809.2), and a single invasive PFGE type within clonal complex 124, which 
was predominantly serotype 14 (OR, 5.7; 95% CI, 1.1–37).
To characterize further the properties of the invasive lineages within complex 138, they did 
whole-genome sequencing on 4 strains, including all three PFGE subtypes. This provided 
clues to suggest that the invasiveness may be due to the presence of specific proteins, but 
despite gene-specific polymerase chain reaction analyses, enzyme-linked immunosorbent 
assays for protein expression, and even virulence assays in mice, in no instance was there a 
single protein or variant allele that specifically differentiated invasive strains from carriage 
strains. It is likely, therefore, that the observed phenotypic differences are due to a 
combination of factors—(1) the presence of multiple genes and/or their genetic variants and 
(2) their levels of expression—that could not be fully discerned by the current analysis.
What these data confirm is that within a highly recombinatorial species such as the 
pneumococcus, our current definitions based on capsular type, multilocus sequence type, or 
PFGE type are insuffi-cient to explain the invasiveness of individual strains and that more 
general application of whole-genome sequencing will be essential if we are to identify 
genes-or, perhaps more importantly, combinations of genes, the expression of which confers 
invasiveness. We may well find that there are multiple routes and multiple solutions to an 
invasive genotype. Why does it matter? We need to know much more in general about 
pneumococcal invasiveness, but at least 2 further steps will help us understand the risk of the 
emergence of replacement invasive strains in a world in which pneumococcal conjugate 
vaccine is widely used. First, using whole-genome sequencing, we should soon be able to 
push open much wider the door that has been opened by Browall et al [2] and define 
invasiveness geno-types and phenotypes beneath the capsule. The second step will be to 
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study the evolution of invasive genotypes when they acquire capsular genes associated with 
less invasive capsules. By maintaining a degree of surveillance at a genomic level of 
resolution, we will be able to observe the evolution of such strains and their future trajectory 
of invasiveness.
The possibility still exists of identifying proteins conferring invasiveness that may be used as 
vaccine candidates, but the relative contribution of capsule versus other determinants of 
invasiveness is still skewed in favor of the capsule. This article reminds us that what lies 
beneath the capsule remains of significant biological interest.
References
1. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and 
geographic stability of the serogroup-specific invasive disease potential of Streptococcus 
pneumoniae in children. J Infect Dis. 2004; 190:1203–11. [PubMed: 15346329] 
2. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships 
between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific 
differences in invasive disease potential. J Infect Dis. 2003; 187:1424–32. [PubMed: 12717624] 
3. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specific properties 
on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004; 189:785–96. [PubMed: 
14976594] 
4. Sjostrom K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci 
will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006; 42:451–9. [PubMed: 
16421787] 
5. Blomberg C, Dagerhamn J, Dahlberg S, et al. Pattern of accessory regions and invasive disease 
potential in Streptococcus pneumoniae. J Infect Dis. 2009; 199:1032–42. [PubMed: 19203261] 
6. Dagerhamn J, Blomberg C, Browall S, Sjostrom K, Morfeldt E, Henriques-Normark B. 
Determination of accessory gene patterns predicts the same relatedness among strains of 
Streptococcus pneumoniae as sequencing of housekeeping genes does and represents a novel 
approach in molecular epidemiology. J Clin Microbiol. 2008; 46:863–8. [PubMed: 18160453] 
7. Brovall S, Norman M, Tångrot J, et al. Intraclonal variations among Streptococcus pneumoniae 
isolates influence likelihood of invasive disease in children. J Infect Dis. 2014; 209:377–88. 
[PubMed: 24009156] 
Klugman et al. Page 3
J Infect Dis. Author manuscript; available in PMC 2017 December 21.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
